Li et al. found that KDM4B activated the AKT signaling pathway by promoting TRAF6-mediated AKT ubiquitination to regulate glucose transporter 1 expression, which in turn promoted glucose metabolism and led to CRC progression [132]. Here, KDM4B is linked to colorectal carcinoma.